BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

BioNTech and OncoC4 to Co-Develop and Commercialize Novel Checkpoint Antibody for Solid Tumor Treatment

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”), a clinical-stage biopharmaceutical company dedicated...

March 20, 2023 | News

AXA Mind Health Study reveals more than half of Gen Z in Asia are suffering from poor mental health

While the COVID-19 pandemic has taken a heavy toll on mind health across society, the latest findings from the annual AXA Study of Mind Health and Wel...

March 20, 2023 | News

Keymed Biosciences Advancing Clinical Progress and Global Collaboration

Development of Innovative and Differentiated Pipelines Core Product CM310 (IL-4Rα antibody): Initiated Phase III registrational cl...

March 18, 2023 | News

RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

Autoimmune diseases occur when the body's immune system becomes oversensitive to proteins that are normally harmless, thus triggering a reaction that leads...

March 18, 2023 | News

Cytiva and TerraCycle expand first-of-its kind recycling program

Ryan Walker, Program Director, Sustainability, Cytiva, says: “The global expansion of our collaboration with TerraCycle demonstrates our commitment t...

March 17, 2023 | News

CANDOR Can Boost Job Satisfaction in Healthcare Workers and Potentially Prevent Burnout

There is widespread concern across the US about the high incidence of burnout among healthcare workers. This situation could result in fewer healthcare wor...

March 17, 2023 | News

CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders

The 20th anniversary edition of the CPHI Pharma Awards is now open for entries, with three new categories created to reflect the surge of innova...

March 17, 2023 | News

Servier's Phase 3 INDIGO trial shows positive results for vorasidenib in IDH-mutant Glioma

Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years Endpo...

March 15, 2023 | News

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Ill...

March 15, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

March 14, 2023 | News

H1 Launches Advanced Diversity Insights and Clinical Trial Performance Insights

H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level ...

March 13, 2023 | News

Huawei Unveils 4 Healthcare Solutions with Ideas for Smart Hospitals

As part of mobile World Congress (MWC) 2023, Huawei held a roundtable for medical media on "Accelerate the Digital Journey of Healthcare, Create New Value ...

March 13, 2023 | News

Merck Achieves Profitable Growth in Challenging Fiscal 2022

Fiscal 2022 Group net sales rise 12.9% to € 22.2 billion EBITDA pre up 12.2% to € 6.8 billion EBITDA pre margin at 30.8% “Big 3&rdquo...

March 13, 2023 | News

Everest Medicines unaffected by Silicon Valley Bank developments.

The company's cash held at SVB is substantially less than 1% of its total cash balance, and amounts not covered by the Federal Deposit Insurance Corporatio...

March 13, 2023 | News

Stay Connected